Learn More
Invitrogen™ Phospho-PKC theta (Ser676) Polyclonal Antibody

Description
A suggested positive control for Western blot is PC12 cells; suggested positive control for IHC is human lung carcinoma; suggested positive control for ICC/IF is Hela cells.
Specifications
Specifications
| Antigen | Phospho-PKC theta (Ser676) |
| Applications | Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 50% glycerol and 0.02% sodium azide; pH 7.4 |
| Gene | PRKCQ |
| Gene Accession No. | Q02111, Q04759, Q9WTQ0 |
| Gene Alias | A130035A12Rik; AW494342; EC 2.7.11.13; kinase nPKC-theta; KPCT; MGC126514; MGC141919; nPKC-theta; PKC theta; PKC-0; Pkcq; PKCtheta; PKC-theta; PRKCQ; PRKCT; protein kinase C theta; protein kinase C theta type; protein kinase C, theta; RP11-563J2.1; si:ch211-239o15.1 |
| Gene Symbols | PRKCQ |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.